Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Recruiting · NCT07256119 · Interventional (participants receive a specific treatment) · Lead sponsor: Ain Shams University
View the official record on ClinicalTrials.gov →Interventions studied
Alpha Lipoic Acid
What this trial is about
the purpose of this study is to evaluate the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Who can take part
Age range
18 Years to 75 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Women aged ≥18 years.
- Histologically confirmed invasive, early-stage breast carcinoma scheduled for adjuvant radiotherapy.
- Receiving total radiation dose of 40 Gy for 15 sessions.
Exclusion criteria
- Prior exposure to radiotherapy.
- Inflammatory or metastatic breast carcinoma.
- Patients with connective tissue disorders.
- Patients with skin inflammatory diseases (e.g. ectopic dermatitis).
- Patients with known allergy or hypersensitivity to alpha lipoic acid.
- Concomitant use of nonsteroidal anti-inflammatory drugs, corticosteroids, or antioxidant medications.
- Patients who will fail to sign the written consent.
Where it is running
1 location listed.
- Zagazig University Hospitals - Zagazig, Egypt